1. Home
  2. > Healthcare
  3. > Pathology Market Trends
Genital Warts (Condyloma Acuminatum)- Epidemiology Forecast–2032

Genital Warts (Condyloma Acuminatum)- Epidemiology Forecast–2032

  • August 2022
  • 83 pages
  • ID: 6316453
  • Format: PDF
  • Delve Insight

Summary

Table of Contents

DelveInsight’s Genital Warts (Condyloma Acuminatum)- Epidemiology Forecast–2032’ report delivers an in-depth understanding of the Genital Warts (Condyloma Acuminatum), historical and forecasted epidemiology as well as the Genital Warts (Condyloma Acuminatum) trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan, and China.

Genital Warts Disease Understanding
Genital warts (also known as anogenital warts, condylomata acuminata, condylomas) are benign proliferative lesions caused by human papillomavirus (HPV) types 6 and 11, which are found in >95% of lesions. Genital warts (GWs) are transmitted by having sexual contact with someone who already has them and may be found on the outside of genitals. Some types, which cause cancer, result in the growth of lesions on a woman’s cervix. It is possible to get genital warts, HPV infection, even if they are not visible. Besides, they look like flesh-colored bumps that have a cauliflower-like appearance, and are usually flat, papular, or pedunculated growths on the genital mucosa, occurring in clusters.
GWs can appear on the penis, vulva, vagina, cervix, groin, or thigh within weeks or months after sexual contact with an infected person. Potentially cancer-causing HPV strains are spread by sexual intercourse, anal sex, and oral sex.

Genital Warts Diagnosis
Genital warts are often diagnosed by appearance. Sometimes a biopsy might be necessary based on indications such as atypical appearance, HIV positive persons, pigmented warts, poor response to the treatment and unclear diagnosis. Clinical diagnosis of GW is based on the appearance of warts, whereas histopathological diagnosis is not routinely indicated. Nucleic Acid Amplification Test for HPV DNA is also recommended. Accurate diagnosis is an essential first step in the treatment of GWs. They can be flat, dome-shaped, keratotic, pedunculated, and cauliflower-shaped; they may occur singularly, in clusters, or as plaques. Understanding the morphological presentation of these lesions is essential to accurate diagnosis of EGWs and their differentiation from other lesions that mimic them. However, warts are not exclusive to external genital tissues. Sexual exposure can be associated with warts in the urethra and at the meatus, cervix, vagina, anus, and oral cavity. Cervical warts, however, require clinicians to rule out high-grade dysplasia using Papanicolaou (Pap) tests before treatment.
Continued in the report…..
Genital Warts Epidemiology Perspective
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Incident cases of Genital Warts, Gender-specific Incident Cases of Genital Warts, Age-specific Incident Cases of Genital Warts, Anatomical Location of Genital Warts in Incident Population in the 7MM+China covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), Japan, and China from 2019 to 2032.
Genital Warts Detailed Epidemiology Segmentation
• In the assessment done , the estimated total incident cases of GWs in the 7MM+China were 1,392,836 in 2021.
• The highest incident cases of GWs were accounted by the US in 2021 (545,316 cases), which are expected to show a rise in the future.
• Among the European countries, Germany had the highest incident population of GWs with 77,210 cases, followed by France, which had incident population of 55,798 in 2021. On the other hand, Spain had the lowest incident population (42,588 cases).
• Japan had 38,043 incident cases for GWs in 2021, accounting for approximately 3% in 7MM+China.

Scope of the Report
• The report covers the descriptive overview of Genital Warts, explaining its symptoms, grading, pathophysiology, and various diagnostic approaches.
• The report provides insight into the 7MM+China historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), Japan, and China.
• The report assesses the disease risk and burden of Genital Warts.
• The report helps to recognize the growth opportunities in the 7MM+China with respect to the patient population.

Report Highlights
• 11-Year Forecast of Genital Warts
• 7MM+China Coverage
• Incident Cases of Genital Warts
• Gender-specific Incident Cases of Genital Warts
• Age-specific Incident Cases of Genital Warts
• Anatomical Location of Genital Warts in Incident Population

Key Questions Answered
• What are the disease risk and burden of Genital Warts?
• What is the historical Genital Warts patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), Japan and China?
• What would be the forecasted patient pool of Genital Warts at the 7MM+China level?
• What will be the growth opportunities across the 7MM+China with respect to the patient population pertaining to Genital Warts?
• Out of the above-mentioned countries, which country would have the highest incident population of Genital Warts during the forecast period (2022–2032)?
• At what CAGR the population is expected to grow across the 7MM+China during the forecast period (2022–2032)?

Reasons to buy
The Genital Warts report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the 7MM+China Genital Warts epidemiology forecast.
• The Genital Warts epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
• The Genital Warts epidemiology model developed is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 11-year forecast period using reputable sources.

Key Assessments
• Patient Segmentation
• Patient Segmentation based on Gender
• Patient Segmentation based on Age
• Patient Segmentation based on Anatomical Location of Genital Warts

Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
• China
Study Period: 2019–2032

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Dupilumab Emerging Drug Insight and Market Forecast ? 2032

  • $ 3250
  • September 2022
  • 30 pages

“Dupilumab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Dupilumab for Chronic Spontaneous Urticaria in seven major markets. A detailed picture of ...

  • Europe
  • Japan
  • Dermatological Condition
  • Industry analysis
  • Health Expenditure

Global Radiodermatitis Industry $ 5600 October 2022

Global Topical Dressings Industry $ 5600 October 2022


ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on